1.Current research status and prospects in artificial intelligence-assisted clinical decision support systems for lung cancer
Ruixin ZHANG ; Jun ZHOU ; Hanwen ZHU ; Xinchen SHEN ; Kaiyuan LI ; Tao CHEN ; Jialiang WEN ; Jiajun DENG ; Yunlang SHE ; Deping ZHAO ; Dong XIE ; Chang CHEN
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery 2026;33(11):1742-1750
Lung cancer ranks first in both incidence and mortality among all malignancies worldwide. Although low-dose computed tomography (LDCT)-based screening has reduced lung cancer mortality to a certain extent, the prognosis of lung cancer patients still leaves much room for improvement. In recent years, artificial intelligence (AI) technologies represented by deep learning have developed rapidly, span the entire diagnostic and therapeutic chain of lung cancer, including screening and early diagnosis, precise staging and treatment decision-making, perioperative management, pathological and molecular diagnosis, and prognostic evaluation, and have gradually evolved from single-modality, single-task architectures toward multimodal fusion models and even general-purpose medical foundation models. This article summarizes the research progress of AI-assisted clinical decision support systems for lung cancer and discusses the challenges and future directions of their clinical translation.
2.Macrophage ATF6 accelerates corticotomy-assisted orthodontic tooth movement through promoting Tnfα transcription.
Zhichun JIN ; Hao XU ; Weiye ZHAO ; Kejia ZHANG ; Shengnan WU ; Chuanjun SHU ; Linlin ZHU ; Yan WANG ; Lin WANG ; Hanwen ZHANG ; Bin YAN
International Journal of Oral Science 2025;17(1):28-28
Corticotomy is a clinical procedure to accelerate orthodontic tooth movement characterized by the regional acceleratory phenomenon (RAP). Despite its therapeutic effects, the surgical risk and unclear mechanism hamper the clinical application. Numerous evidences support macrophages as the key immune cells during bone remodeling. Our study discovered that the monocyte-derived macrophages primarily exhibited a pro-inflammatory phenotype that dominated bone remodeling in corticotomy by CX3CR1CreERT2; R26GFP lineage tracing system. Fluorescence staining, flow cytometry analysis, and western blot determined the significantly enhanced expression of binding immunoglobulin protein (BiP) and emphasized the activation of sensor activating transcription factor 6 (ATF6) in macrophages. Then, we verified that macrophage specific ATF6 deletion (ATF6f/f; CX3CR1CreERT2 mice) decreased the proportion of pro-inflammatory macrophages and therefore blocked the acceleration effect of corticotomy. In contrast, macrophage ATF6 overexpression exaggerated the acceleration of orthodontic tooth movement. In vitro experiments also proved that higher proportion of pro-inflammatory macrophages was positively correlated with higher expression of ATF6. At the mechanism level, RNA-seq and CUT&Tag analysis demonstrated that ATF6 modulated the macrophage-orchestrated inflammation through interacting with Tnfα promotor and augmenting its transcription. Additionally, molecular docking simulation and dual-luciferase reporter system indicated the possible binding sites outside of the traditional endoplasmic reticulum-stress response element (ERSE). Taken together, ATF6 may aggravate orthodontic bone remodeling by promoting Tnfα transcription in macrophages, suggesting that ATF6 may represent a promising therapeutic target for non-invasive accelerated orthodontics.
Animals
;
Mice
;
Macrophages/metabolism*
;
Tumor Necrosis Factor-alpha/genetics*
;
Tooth Movement Techniques/methods*
;
Activating Transcription Factor 6/metabolism*
;
Bone Remodeling
;
Flow Cytometry
;
Blotting, Western
3.Efficacy and safety of omalizumab in the treatment of chronic urticaria: a retrospective analysis
Nali YANG ; Qiuyang XU ; Hanwen WU ; Yahui YE ; Jiling ZHU ; Jingjing LIU ; Zhiming LI
Chinese Journal of Dermatology 2023;56(6):518-524
Objective:To retrospectively analyze clinical efficacy and safety of omalizumab in the treatment of chronic urticaria (CU) in southern Zhejiang, China.Methods:A retrospective observational study was conducted on CU patients who received omalizumab treatment at the First Affiliated Hospital of Wenzhou Medical University from January 1st, 2018 to August 1st, 2021. Through the outpatient follow-up visits, the disease activity, condition control, and quality of life were evaluated using the 7-day urticaria activity score (UAS7) , urticaria control test (UCT) , and dermatology life quality index (DLQI) . In addition, changes in disease condition, recurrence after withdrawal, and adverse events were assessed. Independent-sample t test was used for intergroup comparisons of normally distributed measurement data, Wilcoxon signed-rank sum test or Kruskal-Wallis H test was used for comparisons of non-normally distributed measurement data, and chi-square test or Fisher′s exact test was used for comparisons of enumeration data. Results:A total of 252 CU patients with poor response to antihistamines were included, with a baseline UCT score of 5.0 ± 2.4 points, a UAS7 score of 25.6 ± 6.2 points, and a DLQI score of 17.5 ± 4.7 points; among them, 204 (81.0%) were treated with omalizumab at an initial dose of 300 mg, and 48 (19.0%) with omalizumab at an initial dose of 150 mg. At the end points (12.0 ± 1.4 months after the start of treatment) , an overall control rate of 90.3% (224/248) was achieved after the omalizumab treatment; concretely, 137 (55.2%) patients achieved complete control (UCT = 16 points) , 87 (35.1%) achieved partial control (12 points ≤ UCT < 16 points) , and 24 (9.7%) showed no response (UCT < 12 points) , while 10 with partial response shifted to complete control after dose increase. During the treatment period, recurrence occurred in 50 patients (36.5%) , of whom 32 patients opted for retreatment with omalizumab, and then 30 (93.8%) achieved partial or complete control. Adverse events were reported in 8 patients (3.2%) , and all were mild or moderate.Conclusion:Omalizumab was effective in the real-world treatment of CU, and could improve patients′ quality of life, with a favorable safety profile.
4.Electroencephalographic microstates in vestibular schwannoma patients with tinnitus.
Chi ZHANG ; Xiaoguang WANG ; Zhiwei DING ; Hanwen ZHOU ; Peng LIU ; Xinmiao XUE ; Wei CAO ; Yuhua ZHU ; Jiyue CHEN ; Weidong SHEN ; Shiming YANG ; Fangyuan WANG
Journal of Southern Medical University 2023;43(5):793-799
OBJECTIVE:
To explore the biomarkers of tinnitus in vestibular schwannoma patients using electroencephalographic (EEG) microstate technology.
METHODS:
The EEG and clinical data of 41 patients with vestibular schwannoma were collected. All the patients were evaluated by SAS, SDS, THI and VAS scales. The EEG acquisition time was 10-15 min, and the EEG data were preprocessed and analyzed using MATLAB and EEGLAB software package.
RESULTS:
Of the 41 patients with vestibular schwannoma, 29 patients had tinnitus and 12 did not have tinnitus, and their clinical parameters were comparable. The average global explanation variances of the non-tinnitus and tinnitus groups were 78.8% and 80.1%, respectively. The results of EEG microstate analysis showed that compared with those without tinnitus, the patients with tinnitus had an increased frequency (P=0.033) and contribution (P=0.028) of microstate C. Correlation analysis showed that THI scale scores of the patients were negatively correlated with the duration of microstate A (R=-0.435, P=0.018) and positively with the frequencies of microstate B (R=0.456, P=0.013) and microstate C (R=0.412, P=0.026). Syntax analysis showed that the probability of transition from microstate C to microstate B increased significantly in vestibular schwannoma patients with tinnitus (P=0.031).
CONCLUSION
EEG microstate features differ significantly between vestibular schwannoma patients with and without tinnitus. This abnormality in patients with tinnitus may reflect the potential abnormality in the allocation of neural resources and the transition of brain functional activity.
Humans
;
Neuroma, Acoustic/complications*
;
Electroencephalography
;
Patients
;
Probability
5. Correlation between endothelial microparticles and subacute 1,2-dichloroethane toxic encephalopathy
Hanwen HU ; Tailing LIU ; Yuqing YAN ; Min TAN ; Feng ZHU ; Jianwu DAI ; Zhibing HU
China Occupational Medicine 2020;47(04):460-462
OBJECTIVE: To explore the correlation between endothelial microparticles(EMPs) and subacute 1,2-dichloroethane(1,2-DCE) toxic encephalopathy. METHODS: A total of 24 patients with subacute 1,2-DCE toxic encephalopathy were selected as the case group, and 24 healthy individuals were selected as the control group using a convenient sampling method. Blood plasma was collected from the fasting venous blood of patients in these two groups, and the level of EMPs in the plasma was detected by flow cytometry. RESULTS: The levels of plasma EMPs of patients in the control group and the case group were(692.0±174.4) ×10~3/L and(839.8±155.8) ×10~3/L respectively. The levels of plasma EMPs in patients with mild, moderate and severe case subgroups were(691.6±101.9) ×10~3/L,(900.6±46.6) ×10~3/L and(1 026.8±69.8)×10~3/L respectively. The EMPs level of patients in the case group was higher than that of the control group(P<0.01). The level of EMPs in the moderate and severe case subgroups was higher than that of the control group and mild case subgroup(P<0.01). CONCLUSION: Endothelial injury was found in patients with subacute 1,2-DCE toxic encephalopathy and endothelial injury is related to the severity of poisoning.
6.Effects of the Mineral Oil Covered M2 Droplet Culture, M16 Droplet Culture, and DMSO on Release of Mouse Oocytes from Diplotene Arrest
Hanwen LI ; Lingling LIU ; Gensong LI ; Shuotong ZHU ; Chunyu LI ; Xin DENG
Journal of China Medical University 2019;48(2):132-135
Objective To study the effects of mineral oil covered M2 culture medium droplet culture, M16 droplet culture, and dimethyl sulfoxide (DMSO) on the morphology and survival rates of mouse oocytes during the release from diplotene arrest. Methods Oocytes were randomly divided into 3 groups and individually cultured for 4 h in M2 covered with mineral oil, M16 covered with mineral oil, and/or M16 only to cause germinal vesicle breakdown (GVBD). The morphological changes and survival rates of oocytes in each group were observed under the microscope. Oocytes were randomly divided into 3 groups and cultured in the medium with 0%, 1%, and 2% DMSO. The effect of DMSO on oocytes was also observed during the release from diplotene arrest. Results The survival rates of oocytes in M2 covered with mineral oil were higher than those in M16 (P < 0.05). There was no statistical difference with respect to release of mouse oocytes from diplotene arrest between the oocytes in M2 covered with mineral oil and oocytes in M16. The shape of oocytes in M2 with mineral oil was better than that of oocytes in M16. The effect of DMSO on the survival rate of oocytes was similar in the medium with 0%, 1% and 2%DMSO. But the effect of 2% DMSO on the release of oocytes was statistically significant (P < 0.01). Conclusion During the release of mouse oocytes from diplotene arrest, oocytes in M2 covered with mineral oil have much better morphology and higher survival rate than those in M16. DMSO (0%, 1% and 2%) has no effect on the survival rate of oocytes. However, 2% DMSO is more effective in promoting the release of mouse oocytes from diplotene arrest.
7.Aldehyde dehydrogenase 2 mediated the protection against ischemia/reperfusion injury in renal tubular epithelial cells induced by ethanol pretreatment
Ming CAI ; Qing YUAN ; Hanwen CUI ; Shanjuan HONG ; Li ZENG ; Quanxing WANG ; Youhua ZHU
Chinese Journal of Organ Transplantation 2012;33(8):451-454
ObjectiveTo investigate the role of aldehyde dehydrogenase 2 (ALDH2) in the protection against tubular epithelial cells (TEC) ischemia/reperfusion (IR)injury induced by pretreatment with ethanol.Methods Mouse primary cultured TECs were pretreated with 50 mM ethanol 3 h before simulation of in vitro IR.Lactate dehydrogenase (LDH) release was assessed to evaluate the protection of ethanol pretreatment on IR injury.Thereafter,TECs were transfected with a negative control siRNA (NC) or an ALDH2-siRNA. The ALDH2 protein levels and ALDH enzymatic activities were assessed 48 h after transfection.Ethanol pretreatment and in vitro IR were performed on those transfected TECs.LDH release was assessed to evaluate the role of ALDH2 in the ethanol pretreatment-induced protection against IR injury.ResultsEthanol pretreatment significantly reduced the LDH release in TECs upon IR insult.As compared with NC group and INTERFERin group,the ALDH2 protein levels were decreased by 82.1%,ALDH enzymatic activities were decreased hy 67.3%,and the protective effect induced by ethanol pretreatment was almost completely abrogated in ALDH2-siRNA group.ConclusionEthanol pretreatment protects TECs against IR injury through ALDH2 dependent pathways.

Result Analysis
Print
Save
E-mail